NCT06607224Completed
Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control in Hospitalized Patients with Type 2 Diabetes.
Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control for Insulin Therapy Adjustment and Decision Making in Noncritical Patients with Type 2 Diabetes Hospitalized in Medical and Surgical Wards.
Source: ClinicalTrials.gov · Last updated 23 Sept 2024
Brief summary (registry, in English)
Type 2 diabetes (T2D) is a common pathology in hospitalized patients and is associated with multiple comorbidities. Moreover, it is widely known that glycemic excursions increase hospital stay, infections, morbidity and mortality. Likewise, asymptomatic hypoglycemia and stress hyperglycemia in hospitalized patients is more frequent due to intercurrent pathology, medication, alteration of counter-regulatory hormones. Therefore, the use of continuous glucose monitoring (CGM) systems would be very useful as it allows early recognition of glycemic excursions and thus improve the management of insulin therapy. The primary objective is to demonstrate the increase in time in range (TIR) with the use of CGM for insulin therapy adjustment in hospitalized patients with T2D during their admission. The investigators randomized, parallel group, 2-arm, 40 participants; 20 in each group, patients with diagnosis of T2D prior to admission.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 5 Sept 2024
- Start date
- 10 Jan 2022
- Primary completion date
- 1 Nov 2023
- Lead sponsor
- Hospital General Universitario Gregorio Marañon
- Diseases
- Type 2 diabetes
- NCT number
- NCT06607224
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 10 Jan 2022 to the primary completion date, 1 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior outpatient CGM use
- Patients on prolonged absolute diets or receiving artificial nutrition
Other illness
- Severe mental illnesses
- Severe cognitive impairment
Other
- Pregnant women
- Chronic use of high doses of ascorbic acid (equivalent to more than 500mg/day)
- Patients hospitalized in Intensive Care Units
- Refusal of informed consent
Who the study is looking for
- Over 18 years old
- Admitted to medical or surgical wards with an expected hospitalization duration of more than 72 hours
- Requiring basal-bolus insulin therapy during hospitalization.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital General Universitario Gregorio Marañón Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.